Related Experiment Video
Updated: Aug 24, 2026

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
Published on: February 28, 2021
Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1
R Scott Williams1, Megan S Lee, D Duong Hau
1Department of Biochemistry, University of Alberta, Edmonton, Alberta, T6G 2H7, Canada.
Abstract:
The BRCT repeats in BRCA1 are essential for its tumor suppressor activity and interact with phosphorylated protein targets containing the sequence pSer-X-X-Phe, where X indicates any residue. The structure of the tandem BRCA1 BRCT repeats bound to an optimized phosphopeptide reveals that the N-terminal repeat harbors a conserved BRCT phosphoserine-binding pocket, while the interface between the repeats forms a hydrophobic groove that recognizes the phenylalanine. Crystallographic and biochemical data suggest that the structural integrity of both binding sites is essential for peptide recognition. The diminished peptide-binding capacity observed for cancer-associated BRCA1-BRCT variants may explain the enhanced cancer risks associated with these mutations.
Insights
The BRCA1 BRCT repeats bind to specific phosphopeptides, crucial for tumor suppression. Mutations in these repeats impair binding, potentially explaining increased cancer risk.
Area of Science:
- Biochemistry
- Structural Biology
- Cancer Biology
Background:
- The BRCA1 protein functions as a tumor suppressor.
- BRCA1's tumor suppressor activity relies on its BRCT repeats.
- BRCT repeats recognize phosphorylated motifs (pSer-X-X-Phe) in target proteins.
Purpose of the Study:
- To elucidate the structural basis of BRCA1 BRCT repeat interaction with phosphopeptides.
- To understand how cancer-associated mutations in BRCA1 BRCT affect phosphopeptide binding.
Main Methods:
- X-ray crystallography to determine the structure of BRCA1 BRCT repeats bound to a phosphopeptide.
- Biochemical assays to assess peptide binding affinity and specificity.
Main Results:
- The structure reveals distinct binding sites within the tandem BRCT repeats: a phosphoserine-binding pocket in the N-terminal repeat and a hydrophobic groove for phenylalanine recognition at the interface.
- Both binding sites are structurally integral and essential for effective phosphopeptide recognition.
- Cancer-associated BRCA1-BRCT variants exhibit reduced phosphopeptide-binding capacity.
Conclusions:
- The structural insights explain the molecular mechanism of BRCA1 BRCT-phosphopeptide interaction.
- Impaired phosphopeptide binding due to mutations in BRCA1 BRCT repeats likely contributes to the loss of tumor suppressor function and increased cancer susceptibility.
More Related Videos
Related Concept Videos
Long-patch Base Excision Repair
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Base Excision Repair
The first step of...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Restarting Stalled Replication Forks
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.

